MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

In Silico Electrophysiology and System Pharmacology Reveal Coupling Between Dopamine Receptors and Ca2+ Channels in Subthalamic Neuronal Cells towards Parkinson’s Disease

C. Mahapatra (Mumbai, India)

Meeting: 2024 International Congress

Abstract Number: 808

Keywords: Dopamine agonists, Dopamine receptor, Parkinson’s

Category: Parkinson’s Disease: Pharmacology and Therapy

Objective: Recent experimental evidence suggests a potential interaction between dopamine D2 receptors (D2R) and N-type Ca2+ channels, impacting the firing patterns of Subthalamic neuronal (STN) cells within the basal ganglia [1]. This in silico study aims to elucidate the underlying mechanisms of this interaction and its effects on resting membrane potential (RMP) and firing patterns dynamics in Parkinson’s Disease (PD).

Background: Parkinson’s Disease pathogenesis involves dopamine levels, dopamine receptors, and STN cell electrical activity.

Method: The study employs a three-fold quantitative model approach. Firstly, biophysical parameters for various ion channels in STN cells are integrated from previous research. Secondly, equations for the GPCR pathway are developed to modulate cAMP concentration, linked with N-type Ca2+ channel conductance. Finally, various pharmacological agents are simulated to explore novel biological insights.

Results: Using the dopamine receptor agonist Bromocriptine (Bromo) at 10 µM, the study investigates altered kinetics of N-type Ca2+ channels and subsequent firing patterns. Results revealed that Bromo modulates N-type Ca2+ channel activation curves, shifting the half activation potential of N-type Ca2+ channels to the more positive side. Dopamine agonists decrease AP frequency, attributed to reduced window current due to D2R activation and decreased N-type K+ channel conductance. Figure 1 illustrates the effects of a dopamine agonist on the simulated firing patterns with a current injection of 100 pA for a duration of 1 ms. It clearly shows the reduced firing frequency (blue solid line) under the effects of the dopamine agonists. The window current to maintain the RMP was reduced because of the activation of D2R receptors and it was counterbalanced by decreasing the K+ channel conductance.

Conclusion: The study suggests potential therapeutic strategies involving K+ channel agonists for PD treatment, potentially replacing dopamine in certain pathological conditions and enhancing spatial memory performance.

Figure 1 Modulating effects of dopamine agonist

Figure 1 Modulating effects of dopamine agonist

References: 1. Ramanathan, S., Tkatch, T., Atherton, J. F., Wilson, C. J., & Bevan, M. D. (2008). D2-like dopamine receptors modulate SKCa channel function in subthalamic nucleus neurons
through inhibition of Cav2. 2 channels. Journal of neurophysiology, 99(2), 442-459.

To cite this abstract in AMA style:

C. Mahapatra. In Silico Electrophysiology and System Pharmacology Reveal Coupling Between Dopamine Receptors and Ca2+ Channels in Subthalamic Neuronal Cells towards Parkinson’s Disease [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/in-silico-electrophysiology-and-system-pharmacology-reveal-coupling-between-dopamine-receptors-and-ca2-channels-in-subthalamic-neuronal-cells-towards-parkinsons-disease/. Accessed October 6, 2026.
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/in-silico-electrophysiology-and-system-pharmacology-reveal-coupling-between-dopamine-receptors-and-ca2-channels-in-subthalamic-neuronal-cells-towards-parkinsons-disease/

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley